223 related articles for article (PubMed ID: 37938504)
1. Frontiers of Ovarian Carcinosarcoma.
Ismail A; Choi S; Boussios S
Curr Treat Options Oncol; 2023 Dec; 24(12):1667-1682. PubMed ID: 37938504
[TBL] [Abstract][Full Text] [Related]
2. Carcinosarcoma of the ovary: a review of the literature.
del Carmen MG; Birrer M; Schorge JO
Gynecol Oncol; 2012 Apr; 125(1):271-7. PubMed ID: 22155675
[TBL] [Abstract][Full Text] [Related]
3. "Carcinosarcoma of the ovary, fallopian tube, and peritoneum: Prognostic factors and treatment modalities".
Rauh-Hain JA; Birrer M; Del Carmen MG
Gynecol Oncol; 2016 Aug; 142(2):248-54. PubMed ID: 27321238
[TBL] [Abstract][Full Text] [Related]
4. Current management of ovarian carcinosarcoma.
Mano MS; Rosa DD; Azambuja E; Ismael G; Braga S; D'Hondt V; Piccart M; Awada A
Int J Gynecol Cancer; 2007; 17(2):316-24. PubMed ID: 17362309
[TBL] [Abstract][Full Text] [Related]
5. Carcinosarcoma of the ovary compared to ovarian high-grade serous carcinoma: impact of optimal cytoreduction and standard adjuvant treatment.
Yalcin I; Meydanli MM; Turan AT; Taskin S; Sari ME; Gungor T; Akbayir O; Ayhan A
Int J Clin Oncol; 2018 Apr; 23(2):329-337. PubMed ID: 29143144
[TBL] [Abstract][Full Text] [Related]
6. Genomic and Molecular Characteristics of Ovarian Carcinosarcoma.
Ramphal K; Hadfield MJ; Bandera CM; Hart J; Dizon DS
Am J Clin Oncol; 2023 Dec; 46(12):572-576. PubMed ID: 37986208
[TBL] [Abstract][Full Text] [Related]
7. Outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal dissemination from ovarian carcinosarcoma.
Lopez-Ramirez F; Sardi A; Studeman K; King MC; Falla-Zuniga LF; Nikiforchin A; Baron E; Nieroda C; Gushchin V; Diaz-Montes T
Eur J Surg Oncol; 2023 Aug; 49(8):1495-1503. PubMed ID: 37068984
[TBL] [Abstract][Full Text] [Related]
8. [Carcinosarcomas in female genital tracts: general review].
Guy JB; Trone JC; Casteillo F; Forest F; Pacaut C; Moncharmont C; Espenel S; Vallard A; Langrand Escure J; Collard O; Peoc'h M; Magné N
Bull Cancer; 2014; 101(7-8):760-4. PubMed ID: 25091658
[TBL] [Abstract][Full Text] [Related]
9. Primary ovarian malignant mixed Müllerian tumor: a rare case report.
Jagtap SV; Jagtap SS; Gudur R; Billawaria S
Ther Adv Rare Dis; 2022; 3():26330040221107389. PubMed ID: 37180422
[TBL] [Abstract][Full Text] [Related]
10. Ovarian Carcinosarcoma with Retroperitoneal Para-Aortic Lymph Node Dissemination Followed by an Unusual Postoperative Complication: A Case Report with a Brief Literature Review.
Kostov S; Kornovski Y; Ivanova Y; Dzhenkov D; Stoyanov G; Stoilov S; Slavchev S; Trendafilova E; Yordanov A
Diagnostics (Basel); 2020 Dec; 10(12):. PubMed ID: 33322259
[No Abstract] [Full Text] [Related]
11. Ovarian carcinosarcoma: Current developments and future perspectives.
Boussios S; Karathanasi A; Zakynthinakis-Kyriakou N; Tsiouris AK; Chatziantoniou AA; Kanellos FS; Tatsi K
Crit Rev Oncol Hematol; 2019 Feb; 134():46-55. PubMed ID: 30771873
[TBL] [Abstract][Full Text] [Related]
12. Two Cases of Carcinosarcomas of the Ovary Involved in Hereditary Cancer Syndromes.
Carnevali IW; Cimetti L; Sahnane N; Libera L; Cavallero A; Formenti G; Riva C; Tibiletti MG
Int J Gynecol Pathol; 2017 Jan; 36(1):64-70. PubMed ID: 27167672
[TBL] [Abstract][Full Text] [Related]
13. Platinum, anthracycline, and alkylating agent-based chemotherapy for ovarian carcinosarcoma.
Signorelli M; Chiappa V; Minig L; Fruscio R; Perego P; Caspani G; Battistello M; Colombo N
Int J Gynecol Cancer; 2009 Aug; 19(6):1142-6. PubMed ID: 19820383
[TBL] [Abstract][Full Text] [Related]
14. [Carcinosarcoma of the ovary].
Muller M; Dupre PF; Lucas B; Simon H; Malhaire JP; Guillemet C; Dessogne P; Pradier O
J Gynecol Obstet Biol Reprod (Paris); 2007 Jun; 36(4):399-402. PubMed ID: 17408876
[TBL] [Abstract][Full Text] [Related]
15. Radical surgical cytoreduction in the treatment of ovarian carcinosarcoma.
Doo DW; Erickson BK; Arend RC; Conner MG; Huh WK; Leath CA
Gynecol Oncol; 2014 May; 133(2):234-7. PubMed ID: 24631447
[TBL] [Abstract][Full Text] [Related]
16. Metastatic ovarian carcinosarcoma in a patient undergoing in-vitro fertilization: A case report.
Flint M; Velasquez J; Carr C; Kolev V; Zakashansky K
Int J Surg Case Rep; 2023 Mar; 104():107937. PubMed ID: 36801768
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy and/or radiotherapy in combination with surgery for ovarian carcinosarcoma.
Shylasree TS; Bryant A; Athavale R
Cochrane Database Syst Rev; 2013 Feb; 2013(2):CD006246. PubMed ID: 23450567
[TBL] [Abstract][Full Text] [Related]
18. Mature Teratoma Associated with Bilateral Ovarian Carcinosarcoma - Accidental Association or Etiopathogenetic Determinism? - Case Report.
Birla R; Catanescu ER; Caragui A; Constantinoiu S;
Chirurgia (Bucur); 2016; 111(5):422-427. PubMed ID: 27819640
[TBL] [Abstract][Full Text] [Related]
19. Gynecologic Cancer InterGroup (GCIG) consensus review for uterine and ovarian carcinosarcoma.
Berton-Rigaud D; Devouassoux-Shisheboran M; Ledermann JA; Leitao MM; Powell MA; Poveda A; Beale P; Glasspool RM; Creutzberg CL; Harter P; Kim JW; Reed NS; Ray-Coquard I
Int J Gynecol Cancer; 2014 Nov; 24(9 Suppl 3):S55-60. PubMed ID: 25341582
[TBL] [Abstract][Full Text] [Related]
20. Malignant mixed mullerian tumour of the ovary: prognostic factor and response of adjuvant platinum-based chemotherapy.
Inthasorn P; Beale P; Dalrymple C; Carter J
Aust N Z J Obstet Gynaecol; 2003 Feb; 43(1):61-4. PubMed ID: 12755351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
